--- title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/285548857.md" description: "In Thursday's pre-market session, several health care stocks experienced significant movements. Agilon Health (AGL) surged 55.6% to $43.33, while Atara Biotherapeutics (ATRA) rose 40.77% to $7.25. Cross Country Healthcare (CCRN) increased by 29.08% to $13.05. Conversely, LosersenGene Therapeutics (ENGN) plummeted 67.5% to $2.88, and Entrada Therapeutics (TRDA) fell 47.6% to $8.4. Pharming (PHAR) and ADMA Biologics (ADMA) also saw declines of 19.62% and 18.86%, respectively. Earnings reports influenced these stock movements." datetime: "2026-05-07T12:06:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285548857.md) - [en](https://longbridge.com/en/news/285548857.md) - [zh-HK](https://longbridge.com/zh-HK/news/285548857.md) --- # 12 Health Care Stocks Moving In Thursday's Pre-Market Session ### Gainers - **Agilon Health** (NYSE:AGL) shares moved upwards by 55.6% to $43.33 during Thursday's pre-market session. The company's market cap stands at $463.9 million. The company's, Q1 earnings came out yesterday. - **Atara Biotherapeutics** (NASDAQ:ATRA) stock moved upwards by 40.77% to $7.25. The market value of their outstanding shares is at $43.8 million. - **Cross Country Healthcare** (NASDAQ:CCRN) stock rose 29.08% to $13.05. The company's market cap stands at $325.5 million. As per the press release, Q1 earnings came out today. - **Aspire Biopharma Holdings** (NASDAQ:ASBP) stock increased by 26.72% to $0.24. - **Inovio Pharmaceuticals** (NASDAQ:INO) stock moved upwards by 18.54% to $1.47. The company's market cap stands at $101.1 million. - **Ernexa Therapeutics** (NASDAQ:ERNA) shares moved upwards by 16.55% to $7.04. The market value of their outstanding shares is at $7.0 million. ### Losers - **enGene Therapeutics** (NASDAQ:ENGN) shares decreased by 67.5% to $2.88 during Thursday's pre-market session. The company's market cap stands at $592.8 million. - **Entrada Therapeutics** (NASDAQ:TRDA) stock fell 47.6% to $8.4. The market value of their outstanding shares is at $622.2 million. - **Pharming** (NASDAQ:PHAR) shares fell 19.62% to $13.18. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out today. - **ADMA Biologics** (NASDAQ:ADMA) stock declined by 18.86% to $8.18. The market value of their outstanding shares is at $2.3 billion. The company's, Q1 earnings came out yesterday. - **Accuray** (NASDAQ:ARAY) shares decreased by 14.3% to $0.41. The company's market cap stands at $54.0 million. The company's, Q3 earnings came out yesterday. - **Zoetis** (NYSE:ZTS) stock declined by 13.68% to $96.01. The company's market cap stands at $46.9 billion. The company's, Q1 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [TRDA.US](https://longbridge.com/en/quote/TRDA.US.md) - [AGL.US](https://longbridge.com/en/quote/AGL.US.md) - [ATRA.US](https://longbridge.com/en/quote/ATRA.US.md) - [CCRN.US](https://longbridge.com/en/quote/CCRN.US.md) - [ADMA.US](https://longbridge.com/en/quote/ADMA.US.md) - [PHAR.US](https://longbridge.com/en/quote/PHAR.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IHF.US](https://longbridge.com/en/quote/IHF.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md) - [INO.US](https://longbridge.com/en/quote/INO.US.md) - [ERNA.US](https://longbridge.com/en/quote/ERNA.US.md) - [ENGN.US](https://longbridge.com/en/quote/ENGN.US.md) - [ARAY.US](https://longbridge.com/en/quote/ARAY.US.md) - [ZTS.US](https://longbridge.com/en/quote/ZTS.US.md) - [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md) - [ENGNW.US](https://longbridge.com/en/quote/ENGNW.US.md) ## Related News & Research - [Entrada Therapeutics Highlights Transformational Year and Pipeline Progress](https://longbridge.com/en/news/286898145.md) - [20:15 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA](https://longbridge.com/en/news/286483885.md) - [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md) - [Zacks Research Issues Optimistic Estimate for UNH Earnings](https://longbridge.com/en/news/286908689.md) - [Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/286549656.md)